martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 11, 2025

Costco (COST) Q1 2026 Earnings Call Transcript

View original at nasdaq.com
Costco (COST) Q1 2026 Earnings Call Transcript Image source: The Motley Fool. DATE Thursday, Dec. 11, 2025 at 5 p.m…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • FY2025 warehouse openings are achieving $192M annualized productivity per warehouse vs $150M for FY2023 openings

    80% confidence
  • Warehouse relocations typically generate 20-60% sales uplift

    80% confidence
  • Excluding tax benefits, net income and EPS grew 13.6% year-over-year in Q1 2026

    80% confidence
  • Q1 was the first quarter where healthcare costs grew at faster pace than sales, creating SG&A headwinds

    80% confidence
  • Long-term geographic target is approximately 50% US and 50% international across Canada, Mexico, Europe, Asia, and Australia

    80% confidence
  • Targeted communications to expiring digitally-signed members showing early success in improving renewal rates

    80% confidence
  • Personalization system launched in Q1 showed positive sales lift

    80% confidence
  • Extended operating hours for executive members generated estimated ~1% sales lift

    80% confidence
  • AI pharmacy inventory system improved in-stock levels to >98% with mid-teens script fill growth

    80% confidence
  • Renewal rate may still see a slight decline over next few quarters due to digitally-signed members with lower renewal rates

    80% confidence
  • Kirkland Signature is growing faster than overall sales with 15-20% value proposition vs national brands

    80% confidence
  • Executive membership upgrades saw a 'nice uptick' from extended hours and Instacart benefits

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Costco (COST) Q1 2026 Earnings Call Transcript — Source | Via News | es.VIA.NEWS